← Leaderboards
Josef Coresh
New York University School Of Medicine
$115,254,828
Attributed
$147,406,575
Total exposure
17
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $16.5M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$147,406,575 · 17
By mechanism
U01$65,349,357 · 3
R01$46,175,258 · 7
N01$19,760,722 · 3
T32$14,518,088 · 1
U54$846,360 · 1
R34$626,353 · 1
Top collaborators
- Morgan Erika Grams13 shared
- Frank R Lin11 shared
- Thomas H Mosley2 shared
- Jennifer Anne Deal1 shared
- Rebecca F Gottesman1 shared
- Adam Peter Spira1 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Morgan Erika Grams$12,889,441
- Henry H Ruiz$722,270
- Lily Y. Young$492,228
Others in their field
Top investigators on “Cohort”
- David R. Weir · University Of Michigan At Ann Arbor$406,814,098
- George R Seage · Abt Associates, Inc.$297,656,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$242,146,554
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
CohortParticipantFollow-UpRisk FactorsResearch PersonnelCommunitiesMeasurementDesignInnovationAffectEvaluationAlzheimer&AposKidneyCollaborationsFundingEventAdultGeneticTrainingPathway InteractionsCardiovascular DiseasesHeart FailureDementiaBase
Grant awards (107)
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028$6,605,599
U01 · FY2025 · HL · contact PI
Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study$2,878,086
R01 · FY2025 · AG
Chronic Kidney Disease Prognosis Consortium (CKD-PC)$854,984
R01 · FY2025 · DK · contact PI
Resource Development Core$281,502
U54 · FY2025 · DK · contact PI
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028$6,700,232
U01 · FY2024 · HL · contact PI
Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study$3,930,675
R01 · FY2024 · AG
Chronic Kidney Disease Prognosis Consortium (CKD-PC)$835,918
R01 · FY2024 · DK · contact PI
Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults$640,990
R01 · FY2024 · DK
Resource Development Core$278,921
U54 · FY2024 · DK · contact PI
Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study$3,406,465
R01 · FY2023 · AG
Chronic Kidney Disease Prognosis Consortium (CKD-PC)$843,137
R01 · FY2023 · DK · contact PI
Resource Development Core$285,937
U54 · FY2023 · DK · contact PI
Chronic Kidney Disease Prognosis Consortium (CKD-PC)$99,921
R01 · FY2023 · DK · contact PI
ARIC Neurocognitive Study (ARIC-NCS) Renewal$7,197,275
U01 · FY2022 · HL · contact PI
Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study$4,123,874
R01 · FY2022 · AG
Cardiovascular Epidemiology Institutional Training$825,946
T32 · FY2022 · HL · contact PI
Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults$721,316
R01 · FY2022 · DK
Chronic Kidney Disease Prognosis Consortium$708,858
R01 · FY2022 · DK · contact PI
ARIC Neurocognitive Study (ARIC-NCS) Renewal$8,485,666
U01 · FY2021 · HL · contact PI
Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial$2,965,803
R01 · FY2021 · AG
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - CORE STUDY OPERATIONS$842,093
N01 · FY2021 · HL · contact PI
Cardiovascular Epidemiology Institutional Training$791,782
T32 · FY2021 · HL · contact PI
Chronic Kidney Disease Prognosis Consortium$716,870
R01 · FY2021 · DK · contact PI
Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults$687,667
R01 · FY2021 · DK
The ARIC-PET Amyloid Imaging Study$520,016
R01 · FY2021 · AG · contact PI
ARIC Neurocognitive Study (ARIC-NCS) Renewal$10,619,383
U01 · FY2020 · HL · contact PI
Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial$2,841,558
R01 · FY2020 · AG
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - CORE STUDY OPERATIONS$820,853
N01 · FY2020 · HL · contact PI
Cardiovascular Epidemiology Institutional Training$773,650
T32 · FY2020 · HL · contact PI
Chronic Kidney Disease Prognosis Consortium$724,883
R01 · FY2020 · DK · contact PI
Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults$718,068
R01 · FY2020 · DK
ARIC Neurocognitive Study (ARIC-NCS) Renewal$9,888,004
U01 · FY2019 · HL · contact PI
Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial$2,469,860
R01 · FY2019 · AG
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - CORE STUDY OPERATIONS$822,394
N01 · FY2019 · HL · contact PI
Cardiovascular Epidemiology Institutional Training$733,538
T32 · FY2019 · HL · contact PI
Chronic Kidney Disease Prognosis Consortium$732,893
R01 · FY2019 · DK · contact PI
CKD Biomarker Consortium-Phase 2: Risk Markers in Blood$410,423
U01 · FY2019 · DK · contact PI
Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial$389,802
R01 · FY2019 · AG
ARIC - JHU FIELD CENTER - DIVERSITY SUPPLEMENT$233,835
N01 · FY2019 · HL · contact PI
Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial$4,129,301
R01 · FY2018 · AG
ARIC Neurocognitive Study (ARIC-NCS) 1 of 5$1,098,334
U01 · FY2018 · HL · contact PI
ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - COHORT VISIT 7PERIOD OF PERFORMANCE - NOVEMBER 1, 2017 - DECEMBER 15, 2019$1,030,410
N01 · FY2018 · HL · contact PI
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - CORE STUDY OPERATIONS$801,480
N01 · FY2018 · HL · contact PI
Chronic Kidney Disease Prognosis Consortium$752,562
R01 · FY2018 · DK · contact PI
Cardiovascular Epidemiology Institutional Training$733,068
T32 · FY2018 · HL · contact PI
CKD Biomarker Consortium-Phase 2: Risk Markers in Blood$413,000
U01 · FY2018 · DK · contact PI
Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial$3,789,799
R01 · FY2017 · AG
ARIC Neurocognitive Study (ARIC-NCS) 1 of 5$1,433,353
U01 · FY2017 · HL · contact PI
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - CORE STUDY OPERATIONS$824,092
N01 · FY2017 · HL · contact PI
Cardiovascular Epidemiology Institutional Training$717,650
T32 · FY2017 · HL · contact PI
Chronic Kidney Disease Prognosis Consortium$641,712
R01 · FY2017 · DK · contact PI
CKD Biomarker Consortium-Phase 2: Risk Markers in Blood$413,000
U01 · FY2017 · DK · contact PI
Cardiovascular Epidemiology Institutional Training$2,726
T32 · FY2017 · HL · contact PI
CLINICAL EXAMINATION CENTER$1,482,748
N01 · FY2016 · HL · contact PI
ARIC Neurocognitive Study (ARIC-NCS) 1 of 5$1,413,822
U01 · FY2016 · HL · contact PI
Cardiovascular Epidemiology Institutional Training$714,734
T32 · FY2016 · HL · contact PI
Chronic Kidney Disease Prognosis Consortium$648,576
R01 · FY2016 · DK · contact PI
CKD Biomarker Consortium-Phase 2: Risk Markers in Blood$413,000
U01 · FY2016 · DK · contact PI
CLINICAL EXAMINATION CENTER$1,895,054
N01 · FY2015 · HL · contact PI
ARIC Neurocognitive Study (ARIC-NCS) 1 of 5$1,359,027
U01 · FY2015 · HL · contact PI
Chronic Kidney Disease Prognosis Consortium$696,162
R01 · FY2015 · DK · contact PI
Cardiovascular Epidemiology Institutional Training$689,868
T32 · FY2015 · HL · contact PI
CKD Biomarker Consortium-Phase 2: Risk Markers in Blood$413,000
U01 · FY2015 · DK · contact PI
Planning a trial of hearing rehabilitative treatment to reduce cognitive decline$291,535
R34 · FY2015 · AG
CLINICAL EXAMINATION CENTER$1,932,883
N01 · FY2014 · HL · contact PI
Chronic Kidney Disease Prognosis Consortium$718,524
R01 · FY2014 · DK · contact PI
Cardiovascular Epidemiology Institutional Training$714,345
T32 · FY2014 · HL · contact PI
Planning a trial of hearing rehabilitative treatment to reduce cognitive decline$334,818
R34 · FY2014 · AG
CLINICAL EXAMINATION CENTER$2,161,551
N01 · FY2013 · HL · contact PI
1 of 5 ARIC Neurocognitive Study (ARIC-NCS)$1,242,115
U01 · FY2013 · HL · contact PI
Cardiovascular Epidemiology Institutional Training$715,466
T32 · FY2013 · HL · contact PI
Proteomic Approach to CKD Biomarker Discovery and Validation$312,185
U01 · FY2013 · DK · contact PI
CLINICAL EXAMINATION CENTER$2,374,518
N01 · FY2012 · HL · contact PI
Cardiovascular Epidemiology Institutional Training$784,011
T32 · FY2012 · HL · contact PI
Proteomic Approach to CKD Biomarker Discovery and Validation$725,994
U01 · FY2012 · DK · contact PI
1 of 5 ARIC Neurocognitive Study (ARIC-NCS)$566,044
U01 · FY2012 · HL · contact PI
CLINICAL EXAMINATION CENTER$2,137,754
N01 · FY2011 · HL · contact PI
1 of 5 ARIC Neurocognitive Study (ARIC-NCS)$1,504,048
U01 · FY2011 · HL · contact PI
Cardiovascular Epidemiology Institutional Training$782,747
T32 · FY2011 · HL · contact PI
Proteomic Approach to CKD Biomarker Discovery and Validation$776,813
U01 · FY2011 · DK · contact PI
Longitudinal Study of Predictors and Consequences of Chronic Kidney Disease$622,648
R01 · FY2011 · DK · contact PI
Proteomic Approach to CKD Biomarker Discovery and Validation$39,999
U01 · FY2011 · DK · contact PI
1 of 5 ARIC Neurocognitive Study (ARIC-NCS)$1,240,198
U01 · FY2010 · HL · contact PI
Atherosclerosis Risk in Communities Study (ARIC)$1,222,739
N01 · FY2010 · HL · contact PI
Proteomic Approach to CKD Biomarker Discovery and Validation$814,233
U01 · FY2010 · DK · contact PI
Cardiovascular Epidemiology Institutional Training$687,297
T32 · FY2010 · HL · contact PI
Proteomic Approach to CKD Biomarker Discovery and Validation$35,000
U01 · FY2010 · DK · contact PI
Atherosclerosis Risk in Communities Study (ARIC)$1,178,318
N01 · FY2009 · HL · contact PI
Proteomic Approach to CKD Biomarker Discovery and Validation$853,063
U01 · FY2009 · DK · contact PI
Cardiovascular Epidemiology Institutional Training$395,799
T32 · FY2009 · HL · contact PI
Cardiovascular Epidemiology Institutional Training$481,484
T32 · FY2008 · HL · contact PI
Cardiovascular Epidemiology Institutional Training$536,207
T32 · FY2007 · HL · contact PI
Refining Estimates of Kidney Function in the U.S.$130,437
U01 · FY2007 · DK · contact PI
Cardiovascular Epidemiology Institutional Training$603,203
T32 · FY2006 · HL · contact PI
Refining Estimates of Kidney Function in the U.S.$115,673
U01 · FY2006 · DK · contact PI
Cardiovascular Epidemiology Institutional Training$534,665
T32 · FY2005 · HL
Refining Estimates of Kidney Function in the U.S.$130,437
U01 · FY2005 · DK
Cardiovascular Epidemiology Institutional Training$498,921
T32 · FY2004 · HL
Refining Estimates of Kidney Function in the U.S.$130,437
R21 · FY2004 · DK
RISK FACTORS FOR CV DISEASE IN A DIALYSIS COHORT$606,961
R01 · FY2003 · HL
CARDIOVASCULAR EPIDEMIOLOGY INSTITUTIONAL TRAINING$324,627
T32 · FY2003 · HL
RISK FACTORS FOR CV DISEASE IN A DIALYSIS COHORT$576,980
R01 · FY2002 · HL
CARDIOVASCULAR EPIDEMIOLOGY INSTITUTIONAL TRAINING$543,120
T32 · FY2002 · HL
RISK FACTORS FOR CV DISEASE IN A DIALYSIS COHORT$584,836
R01 · FY2001 · HL
CARDIOVASCULAR EPIDEMIOLOGY INSTITUTIONAL TRAINING$508,274
T32 · FY2001 · HL
RISK FACTORS FOR CV DISEASE IN A DIALYSIS COHORT$595,553
R01 · FY2000 · HL
CARDIOVASCULAR EPIDEMIOLOGY INSTITUTIONAL TRAINING$424,960
T32 · FY2000 · HL